- All Articles
- Biologics Zone
- Blood Management
- Circuit Surfers
- ECMO Zone
- Education Zone
- HIPEC Zone
- i-Pump Quick Reference
- Main Zone
- Mobile Zone
- Multimedia Zone
- Pediatric Zone
- Perfusion Devices
- Perfusion Zone
- Premium Zone
- Press Release
- Tiny Perfusion Letter
- Warnings and Recalls
Global Effort to Collect Data on Ventilated Patients With COVID-19
They called their study ECMOCARD, short for Extracorporeal Membrane Oxygenation for novel Coronavirus Acute Respiratory Disease.
Covid-19: General Guidelines For Cardiovascular Surgeons (standard guidelines – subject to change)
Important considerations should be given to our readers regarding cardiac surgery, surgical teams, our patients, and their possible contacts.
Convalescent Plasma Transfusion for the Treatment of COVID‐19: Systematic Review
Based on the limited scientific data, CPT therapy in COVID‐19 patients appears safe, clinically effective, and reduces mortality.
COVID-19: 10 Things I Wished I’d Known Some Months Ago
This viewpoint addresses 10 points that may be of interest both the logistics, as well as actual clinical care of critically ill COVID-19 patients.
Restarting with Covid-19: Seven Key Action Items
Leaders at NewYork-Presbyterian have created a Restart Coordination Committee to develop and execute a measured approach for the way forward.
Safety for All: Coronavirus Disease 2019 Pandemic and Cardiac Surgery: a Roadmap to ‘Phase’ 2
Health care communities need to develop a strategy to restart non-COVID medical and surgical care. To achieve this goal safely, they need to develop a ‘roadmap’.
COVID-19 and ECMO: the Interplay Between Coagulation and Inflammation—a Narrative Review
The present review summarizes the evidence on ECMO management of severe ARDS in light of recent COVID-19 pandemic, at the same time focusing on differences and similarities between SARS-CoV-2 and ECMO in terms of hematological and inflammatory interplay when these two settings merge.
Should COVID-19 Take Advice from Rheumatologists?
Although the degree and extent of systemic inflammation seen in patients with COVID-19 is typically less than in haemophagocytic lymphohistocytosis and macrophage activation syndrome, many observational studies have identified associations between inflammatory biomarkers
COVID-19 in Cardiac Surgery: A Proposed Prioritization Framework
A prioritization framework based on already published risks scores and guidelines for appropriate use are described as an added tool to supplement thorough patient assessment and sound clinical judgment.
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
We assessed association between administration of in-hospital AC and survival in a large cohort of hospitalized patients with COVID-19.
High Risk of Thrombosis in Patients with Severe SARS-CoV-2 Infection: a Multicenter Prospective Cohort Study
Despite anticoagulation, a high number of patients with ARDS secondary to COVID-19 developed life-threatening thrombotic complications. Higher anticoagulation targets than in usual critically ill patients should therefore probably be suggested.
Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership
As regions move along the journey of managing the COVID-19 pandemic,
there is an opportunity to reintroduce regular cardiovascular care in a progressive manner with
Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical Recovery
These are guidance recommendations during a pandemic surge to be utilized for ALL patients while local COVID-19 disease burden remains elevated.
Clinical and Laboratory Predictors of In-Hospital Mortality in Patients with COVID-19: a Cohort Study in Wuhan, China
We developed two predictive models for the in-hospital mortality of patients with COVID-19 in Wuhan and validated in patients from another center.
Anesthesia and COVID-19: What We Should Know and What We Should Do
Through a comprehensive review of existing studies on COVID-19, this article presents the epidemiological and clinical characteristics of COVID-19, reviews current medical management, and suggests ways to improve the safety of anesthetic procedures.
Characteristics, Treatment, Outcomes and Cause of Death of Invasively Ventilated Patients with COVID-19 ARDS in Milan, Italy
Despite multiple advanced critical care interventions, COVID-19 ARDS was associated with prolonged ventilation and high short term mortality. Older age and pre-admission hypertension were key mortality risk factors.
NIH COVID-19 Treatment Guidelines
These Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19.
Incidence of Thrombotic Complications in Critically Ill ICU Patients with COVID-19
Our findings reinforce the recommendation to strictly apply pharmacological thrombosis prophylaxis in all COVID-19 patients admitted to the ICU, and are strongly suggestive of increasing the prophylaxis towards high-prophylactic doses, even in the absence of randomized evidence.
Regional Planning for Extracorporeal Membrane Oxygenation Allocation During COVID-19
Drawing from a collaborative framework developed by one United States metropolitan area with multiple adult and pediatric extracorporeal life support centers, this article aims to inform decision-making around ECMO use during a pandemic such as COVID-19.
Protecting High-Risk Cardiac Patients During the COVID-19 Outbreak
During the ongoing health emergency, all new patients admitted to hospital units hosting immunocompromised; complex; critical; and, more generally, acutely ill patients probably should be isolated initially and screened for SARS-CoV-2 infection, and separate pathways should be provided until the virological test results are obtained.
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
The Surviving Sepsis Campaign COVID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19. When available, we will provide new recommendations in further releases of these guidelines.
Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19
For now—and possibly the next 18 to 24 months, convalescent plasma, despite supply issues and questions about efficacy and who is most likely to benefit from treatment, remains the only off-the-shelf therapy for COVID-19.
Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy
The cumulative incidence of out-of-hospital cardiac arrest in 2020 was strongly associated with the cumulative incidence of Covid-19, and the increase in the number of cases of out-of-hospital cardiac arrest over the number in 2019 followed the time course of the Covid-19 outbreak
The Essential Role of Patient Blood Management in a Pandemic: A Call for Action
This multinational and diverse group of authors issue this “Call to Action” underscoring “The Essential Role of Patient Blood Management in the Management of Pandemics” and urging all stakeholders and providers to implement the practical and common-sense principles of PBM and its multi-professional and multimodality approaches.